肾上腺皮质功能不全患者的生活质量及其决定因素:美国3个中心的调查研究
这项多中心横断面调查研究使用以患者为中心的问卷简表-36,纳入529例肾上腺皮质功能不全患者,其中原发性223例(42.2%)、继发性190例(35.9%)、糖皮质激素诱导性116例(21.9%)。多变量分析显示女性、继发性或糖皮质激素诱导性、病程较短、氢化可的松等效剂量每日超过25 mg、更多糖皮质激素过量相关合并症、更高经济负担、管理困难及缺乏家庭支持与较差的生活质量评分相关。
要点
- 女性、继发性或糖皮质激素诱导性、病程较短与较差的躯体评分相关。
- 氢化可的松等效剂量每日超过25 mg、更多合并症、更高经济负担与管理困难与较差的躯体评分相关。
- 缺乏家庭支持与较差的心理成分评分相关(OR 9.1;95% CI,2.3-33.3)。
核心结论
- 在肾上腺皮质功能不全患者中,通过处理某些决定因素可能改善生活质量,如避免糖皮质激素过度替代、提供深入的自我管理教育、提供更全面的保险覆盖以及确保更好的家庭支持。
研究设计与样本
- 多中心横断面调查研究,使用以患者为中心的问卷简表-36,共纳入529例肾上腺皮质功能不全患者。
主要发现
- 529例参与者中,原发性肾上腺皮质功能不全223例(42.2%),继发性190例(35.9%),糖皮质激素诱导性116例(21.9%);中位年龄58岁(四分位距:43-68岁),女性342例(64.8%)。
- 多变量分析中,女性(OR:3.3;95% CI,1.8-6.0)、继发性或糖皮质激素诱导性(OR:2.5;95% CI,1.4-4.3)、病程较短(OR:2.0;95% CI,1.1-3.6)、氢化可的松等效剂量每日超过25 mg(OR:2.3;95% CI,1.2-4.6)、更多糖皮质激素过量相关合并症(OR:2.3;95% CI,1.3-4.0)、更高经济负担(OR:2.1;95% CI,1.3-3.6)及管理困难(OR:2.5;95% CI,1.2-5.2)与更差的躯体评分相关。
- 女性(OR:2.1;95% CI,1.08-4.0)、病程较短(OR:2.4;95% CI,1.4-4.3)、更高经济负担(OR:2.3;95% CI,1.3-4.0)、管理困难(OR:2.6;95% CI,1.4-4.9)及缺乏家庭支持(OR:9.1;95% CI,2.3-33.3)与更差的心理成分评分相关。
临床怎么用
- 作者认为,在肾上腺皮质功能不全患者中,通过处理某些决定因素可能改善生活质量,如避免糖皮质激素过度替代、提供深入的自我管理教育、提供更全面的保险覆盖以及确保更好的家庭支持。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Current evidence on determinants of quality of life (QoL) in patients with adrenal insufficiency (AI) is limited. OBJECTIVE: This work aimed to identify the determinants of QoL in different subtypes of AI. METHODS: This multicenter cross-sectional survey study was conducted using a patient-centered questionnaire, the Short Form-36. RESULTS: Of 529 participants, 223 (42.2%) had primary AI, 190 (35.9%) had secondary AI, and 116 (21.9%) had glucocorticoid-induced AI. Median age was 58 years (interquartile range: 43-68 years) and 342 (64.8%) were women. In multivariable analyses, patients were more likely to report worse physical scores if they were women (odds ratio [OR]: 3.3; 95% CI, 1.8-6.0), had secondary AI or glucocorticoid-induced AI (OR: 2.5; 95% CI, 1.4-4.3), had shorter duration of AI (OR: 2.0; 95% CI, 1.1-3.6), were treated with more than 25 mg hydrocortisone equivalent daily (OR: 2.3; 95% CI, 1.2-4.6), had more comorbidities related to glucocorticoid excess (OR: 2.3; 95% CI, 1.3-4.0), reported a higher financial burden from AI (OR: 2.1; 95% CI, 1.3-3.6), and reported difficulties with AI management (OR: 2.5; 95% CI, 1.2-5.2). Women (OR: 2.1; 95% CI, 1.08-4.0), shorter duration of AI (OR: 2.4; 95% CI, 1.4-4.3), higher financial burden (OR: 2.3; 95% CI, 1.3-4.0), difficulties with AI management (OR: 2.6; 95% CI, 1.4-4.9), and lack of family support (OR: 9.1; 95% CI, 2.3-33.3) were associated with worse mental component scores. CONCLUSION: In patients with AI, QoL could be improved by addressing certain determinants, such as avoiding GC overreplacement, providing in-depth education on self-management, offering more comprehensive insurance coverage, and ensuring better family support.
引用
- Li D, Brand S, Hamidi O, et al. Quality of Life and its Determinants in Patients With Adrenal Insufficiency: A Survey Study at 3 Centers in the United States. J Clin Endocrinol Metab. 2022. PMID: 35350067. doi:10.1210/clinem/dgac175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。